At MedservRegis we place great importance on responsible corporate governance. Although we acknowledge that the Code of Good Corporate Governance does not dictate or prescribe mandatory rules but recommends principles of good practice, the directors strongly believe that such practices are in the best interests of the Company and its shareholders.

We believe that compliance with principles of good corporate governance is not only expected by investors but also evidences the directors’ and the Company’s commitment to a high standard of governance.

The Company’s latest corporate governance statement may be found in the ‘Directors’ statement of Compliance with the Code of Principles of Good Corporate Governance’ section of their Annual Report.

Company Secretary: Dr. Laragh Cassar

The Board delegates specific responsibilities to the Audit Committee, the Remuneration Committee and the Financial Risk Committee.

Audit Committee

Keith Grunow (Chairman)

Monica Vilabril

Dr. Laragh Cassar

 

Remuneration Committee

Keith Grunow (Chairman)

Monica Vilabril

Dr. Laragh Cassar

 

Financial Risk Committee

Olivier Bernard (Chairman)

Carmelo sive Karl Bartolo

Alessandro Roca

Silvio Camilleri

Salman Manjoo

 

The Executive management of MedservRegis plc is composed of the following:

Executive Management	Role
Mr David O’Connor	Chief Executive Officer
Mr Carmelo sive Karl Bartolo	Deputy CEO for Business and Operations
Mr Olivier Bernard	Deputy CEO for Finance, Administration, Investment and Trading
Mr Alessandro Roca	Group Finance Director
Mr Silvio Camilleri	Chief Financial Officer
Mr Edward Farrugia	Chief Information Officer
Mr George Douglas	Chief Health, Safety, Security, Environmental and Quality Officer
Ms Linda De Beer	Chief HR Officer

 

The statutory auditors of the Company are PricewaterhouseCoopers.